Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
bacterial infection
cerebrovascular accident
cerebrovascular accident, mimics
chlorpropamide
coma
diabetes mellitus
drug induced neurologic disorders
genetic neurologic disorders
hemiparesis
hypoglycemia
hypoglycemic agent, oral
hypoglycemic coma
iatrogenic neurologic disorders
insulin
level of consciousness, decreased
mimics
mortality
old age, neurology of
optic neuropathy
optic neuropathy, toxic
seizure
tolazamide
transketolase
visual loss
Wernicke's encephalopathy
Showing articles 1750 to 1800 of 4542 << Previous Next >>

Discontinuation of Statin Treatment in Stroke Patients
Stroke 37:2640-2643, Endres,M. &Laufs,U., 2006

Leukoencephalopathy Induced by Levamisole Alone for the Treatment of Recurrent Aphthous Ulcers
Neurol 67:1065-1067, Liu,J.M.,et al, 2006

An Expedited Code Stroke Protocol Is Feasible and Safe
Stroke 37:2935-2939,2863, Sattin,J.A.,et al, 2006

The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke 37:2957-2962,2865, Kent,D.M.,et al, 2006

Immediate Anticoagulation for Acute Stroke in Atrial Fibrillation: Yes
Stroke 37:3052-3053,3056, Chamorro,., 2006

Immediate Angicoagulation for Acute Stroke in Atrial Fibrillation: No
Stroke 37:3054-3055,3056, Sandercock,P., 2006

Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke 37:2963-2969, Kent,D.M.,et al, 2006

Long-Term Effect of Intra-Arterial Thrombolysis in Stroke
Stroke 37:3002-3007, Nedeltchev,K.,et al, 2006

Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006

Prediction of Thrombolytic Efficacy in Acute Ischemic Stroke Using Thin-Section Noncontrast CT
Neurol 67:1846-1848, Kim,E.Y.,et al, 2006

Outcome of Acute Vertebrobasilar Occlusions Treated with Intra-Arterial Fibrinolysis in 180 Patients
AJNR 27:2042-2047, Schulte-Altedorneburg,G.,et al, 2006

Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006

Immune Reconstitution Inflammatory Syndrome Associated with PML in AIDS: A Treatable Disorder
Neurol 67:1692-1694, Martinez,J.V.,et al, 2006

Predicting Abnormal Coagulation in Ischemic Stroke: Reducing Delay in rt-PA Use
Neurol 67:1665-1667, Gottesman,R.F.,et al, 2006

Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage
Stroke 37:151-155,6, Goldstein,J.N.,et al, 2006

Self-Monitoring of Oral Anticoagulation: A Systematic Review and Meta-Analysis
Lancet 367:404-411,412, Heneghan,C.,et al, 2006

Charcot Neuroarthropathy in the Era of HAART
Lancet 367:274, Oh-Park,M.,et al, 2006

Extrathymic Tumors in Patients With Myasthenia Gravis, A 35-Year Retrospective Study
The Neurologist 12:53-55, Wakata,N.,et al, 2006

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke 37:556-561, Trouillas,P. &von Kummer,R., 2006

Cerebral Microhemorrhage
Stroke 37:550-555, Viswanathan,A. &Chabriat,H., 2006

Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006

Endovascular Recanalization Therapy in Acute Ischemic Stroke
Stroke 37:419-424, Choi,J.H.,et al, 2006

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006

Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Circulation 114:759-765, Oral,H.,et al, 2006

Cyanide Intoxication with Encephalitis Clinic: A Case Report
East J Med 11:22-25, Dogan, M.,et al, 2006

Intravascular Lymphoma: The Oncologists "Great Imitator"
The Oncologist 11:496-502, Zuckerman, D.,et al, 2006

Location and Outcome of Anticoagulant-Associated Intracerebral Hemorrhage
Neurocrit Care 05:197-201, Flaherty, M.L.,et al, 2006

Diffusion-Weighted Cranial MR Imaging Findings in a Patient with Hemophagocytic Syndrome
AJNR 27:1312-1314, Ozgen, B.,et al, 2006

Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded, Randomized Study
J Clin Oncol 24:1904-1909, Low, W.K.,et al, 2006

Clinical Study of 99 Patients with Pure Sensory Stroke
J Neurol 252:156-162, Arboix, A.,et al, 2005

Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005

Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005

Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005

Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005

Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005

Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005

Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005

Capecitabine-Induced Multifocal Leukoencephalopathy: A Report of Five Cases
Neurol 65:1792-1794, Videnovic,A.,et al, 2005

Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005

Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Reversible Anorgasmia With Topiramate Therapy for Migraine
Neurol 65:1333-1334, Newman,L.C.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

Evaluation of Combination Therapy Using Aciclovir and Corticosteroid in Adult Patients with Herpes Simplex Virus Encephalitis
JNNP 76:1544-1549,1469, Kamei,S.,et al, 2005



Showing articles 1750 to 1800 of 4542 << Previous Next >>